Overview

A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants

Status:
Active, not recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study in healthy participants is to learn more about the safety of LY3509754 and any side effects that might be associated with it. Blood tests will be performed to check how much LY3509754 gets into the bloodstream and how long it takes the body to eliminate it.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Itraconazole
Midazolam